Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2024 Filed Feb 28, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-24-028785 · tm247055-35_4seq1.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 7, 2023. F3 · derivative.exercise_date: The option vested in four equal annual installments beginning on March 3, 2016. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
SaleCommon Stock | 5,000 | $30.21 | $151,050.00 |
DisclosureSEC source: 0001104659-24-028785 · tm247055-35_4seq1.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,570 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 7, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.13 to $30.35. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionCommon Stock | 5,000 | $9.13 | $45,650.00 |
DisclosureSEC source: 0001104659-24-028785 · tm247055-35_4seq1.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 7, 2023. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:04 UTC |
NEWHALL CHARLES W IIIDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028281 · tm247055-15_4seq1.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,886 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:04 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028281 · tm247055-15_4seq1.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,975 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028272 · tm247055-23_4seq1.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 567 | $29.06 | $16,477.02 |
DisclosureSEC source: 0001104659-24-028272 · tm247055-23_4seq1.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,641 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028272 · tm247055-23_4seq1.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,208 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:02 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028276 · tm247055-20_4seq1.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 1,875 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:02 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Tax withholdingCommon Stock | 937 | $29.06 | $27,229.22 |
DisclosureSEC source: 0001104659-24-028276 · tm247055-20_4seq1.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,249 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:02 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028276 · tm247055-20_4seq1.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,186 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:03 UTC |
Hudson Frederick M.Director
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028278 · tm247055-18_4seq1.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,886 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:03 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028278 · tm247055-18_4seq1.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,117 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:02 UTC |
SIEBERT JOHN MDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028277 · tm247055-19_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,886 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:02 UTC |
SIEBERT JOHN MDirector
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028277 · tm247055-19_4seq1.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,943 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028273 · tm247055-22_4seq1.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,314 | $29.06 | $38,184.84 |
DisclosureSEC source: 0001104659-24-028273 · tm247055-22_4seq1.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,190 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028273 · tm247055-22_4seq1.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,504 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:04 UTC |
GEMAYEL GEORGESDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028279 · tm247055-17_4seq1.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,886 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:04 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028279 · tm247055-17_4seq1.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,201 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:04 UTC |
Barlow CarroleeDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028280 · tm247055-16_4seq1.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,886 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:04 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028280 · tm247055-16_4seq1.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,201 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028275 · tm247055-21_4seq1.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 638 | $29.06 | $18,540.28 |
DisclosureSEC source: 0001104659-24-028275 · tm247055-21_4seq1.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,570 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:01 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028275 · tm247055-21_4seq1.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,208 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028269 · tm247055-24_4seq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Tax withholdingCommon Stock | 485 | $29.06 | $14,094.10 |
DisclosureSEC source: 0001104659-24-028269 · tm247055-24_4seq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,933 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-028269 · tm247055-24_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,418 Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:02 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027579 · tm247055-7_4seq1.xml · derivative · entry 3 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:02 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027579 · tm247055-7_4seq1.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027581 · tm247055-12_4seq1.xml · derivative · entry 5 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-02-22 F6 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027581 · tm247055-12_4seq1.xml · derivative · entry 4 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027581 · tm247055-12_4seq1.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 303 | $27.94 | $8,465.82 |
DisclosureSEC source: 0001104659-24-027581 · tm247055-12_4seq1.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,958 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027581 · tm247055-12_4seq1.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,261 F1 · balance_after: Includes an aggregate of 268 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantPerformance Share Unit · Derivative | 990 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · derivative · entry 6 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 990 Underlying: Common Stock · 990 shares Expires not disclosed F7 · derivative.exercise_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. F7 · derivative.expiration_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · derivative · entry 5 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-02-22 F6 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · derivative · entry 4 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Tax withholdingCommon Stock | 335 | $27.94 | $9,359.90 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,311 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027571 · tm247055-4_4seq1.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,646 F1 · balance_after: Includes an aggregate of 215 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:01 UTC |
Hudson Frederick M.Director
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027574 · tm247055-11_4seq1.xml · derivative · entry 3 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:01 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027574 · tm247055-11_4seq1.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:01 UTC |
SIEBERT JOHN MDirector
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027576 · tm247055-10_4seq1.xml · derivative · entry 3 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:01 UTC |
SIEBERT JOHN MDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027576 · tm247055-10_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027567 · tm247055-3_4seq1.xml · derivative · entry 4 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-02-22 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027567 · tm247055-3_4seq1.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027567 · tm247055-3_4seq1.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027567 · tm247055-3_4seq1.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,004 F1 · balance_after: Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:03 UTC |
GEMAYEL GEORGESDirector
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027583 · tm247055-8_4seq1.xml · derivative · entry 3 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.